Tag:
Alzheimer's
Latest Headlines
Latest Headlines
Salk compound protects against Alzheimer's-related disease behaviors
In what could be a breakthrough in drug development for the elusive Alzheimer's disease, researchers at the La Jolla, CA-based Salk Institute for Biological Studies have designed a drug that reverses memory deficits and slows progression of the disease in mice after short-term treatment.
Hong Kong billionaire backs Big Data effort in biomedicine at Oxford University
Oxford University is marshaling money and scientists to explore massive datasets to uncover knowledge about diseases and treatments.
Australian team advances Alzheimer's blood test work
Researchers at Australia's national science agency believe their effort to develop a blood test to detect early-stage Alzheimer's has reached a major milestone.
Biotech startup hustles new Alzheimer's program to the clinic
Back in early 2012, a number of physicians around the U.S. began fielding some unusual requests from Alzheimer's patients for a prescription covering Targretin (bexarotene), a cancer drug sold by Eisai.
Siemens selling Alzheimer's Dx agents to Lilly
Eli Lilly plans to buy two of Seimens Healthcare Alzheimer's imaging agents, used in PET scans, all part of the drugmaker's shifting approach to treating the disease.
UPDATED: Eli Lilly rolls the dice on combo approach against Alzheimer's disease
Undeterred by its past failures in the Alzheimer's field, Eli Lilly has invested more in research on drugs that target tangles of tau in the brains of patients with the memory-robbing disease. And the company is open to exploring combo treatments that home in on multiple culprits in the dementia, a company official tells The Wall Street Journal .
High cholesterol may cause chromosome defects connected to Alzheimer's
High cholesterol is often named as a risk factor for heart disease and stroke, but it may be connected to another disease as well--Alzheimer's.
CEO Chris Viehbacher steers Sanofi clear of drugs for Alzheimer's disease
Sanofi CEO Chris Viehbacher says the French drugmaker is not interested in pursuing Alzheimer's drugs until the science of the disease is better understood.
Indian CMO Shasun inks Alzheimer's deal with Debiopharm
Swiss drugmaker Debiopharma has teamed up with India's Shasun Pharmaceuticals, striking a deal with the CMO to manufacture Huperzine-A, a drug designed to improve cognitive performance in patients with Alzheimer's disease.
New rat model could help scientists better understand, treat Alzheimer's
For the first time, scientists have genetically engineered a lab rat that has the full range of brain changes associated with Alzheimer's disease--that is, it more accurately mirrors the brain of a person with the disease.
